← Back

Telangana Pharma Hub Gets Centre Of Excellence Status

General • February 14, 2026

Telangana Pharma Hub Gets Centre Of Excellence Status is drawing significant interest across the industry.

The PRIP scheme, with an outlay of ?5,000 crore till FY 2030, supports R&D across the pharma–medtech lifecycle — from early research to product development and commercialisation.

Experts suggest this could influence future trends and innovation in the sector.

More updates are expected as the story develops.


Related Articles

Source: Original →